AbClon Amends Contract End Date to August 31 for Supply Deal with MFDS No Financial Impact


  • AbClon disclosed an amendment to its supply contract with the Ministry of Food and Drug Safety National Institute of Food and Drug Safety Evaluation.
  • The revision extends the contract end date from June 30 2026 to August 31 2026 due to settlement and administrative procedures.
  • The contract amount remains unchanged at 355,762,000 KRW representing 7.5% of AbClon's 2025 individual revenue of 4,714,084,167 KRW.
  • [AI Summary]This amendment is a routine administrative change to the contract end date with no alteration to contract size or terms. The impact on shareholder value is neutral and does not constitute a material factor for investment decisions.

KOSDAQ Filing Information


  • [Correction Of Description] Conclusion Of Single Sales And Supply Agreement (Voluntary Disclosure)
  • Company: AbClon (174900)
  • Submission: AbClon Inc.
  • Under KRX KOSDAQ Market Division

  • Shares: 19,952,129
  • Price: 30,050 KRW
  • Market Cap: 599.6 B KRW